Skip to main content
. Author manuscript; available in PMC: 2010 Jul 22.
Published in final edited form as: J Am Chem Soc. 2009 Jul 22;131(28):9695–9703. doi: 10.1021/ja9006707

Figure 7. Monitoring the presence of infused MART-1-specific, TCR-engineered T cells.

Figure 7

(A) Flow cytometry plots (top panels) and NACS (bottom panels) monitoring the transduction of T cells with a MART-1-specific TCR. (B) Blood cells from patient F5-1 were collected at days 0, 9, 14 and 30 after infusion. The abundance of MART-1-specific T cells was monitored by NACS (left axis) and flow cytometry (right axis).